Manish Mittal1, Saroj Nepal1, Yoshikazu Tsukasaki1, Claudie M Hecquet1, Dheeraj Soni1, Jalees Rehman1, Chinnaswamy Tiruppathi1, Asrar B Malik2. 1. From the Department of Pharmacology (M.M., S.N., Y.T., C.M.H., D.S., J.L., C.T., A.B.M.), and Department of Medicine, University of Illinois College of Medicine (J.L.). 2. From the Department of Pharmacology (M.M., S.N., Y.T., C.M.H., D.S., J.L., C.T., A.B.M.), and Department of Medicine, University of Illinois College of Medicine (J.L.). abmalik@uic.edu.
Abstract
RATIONALE: TRPM2 (transient receptor potential melastatin-2) expressed in endothelial cells (ECs) is a cation channel mediating Ca2+ entry in response to intracellular generation of adenosine diphosphoribose-the TRPM2 ligand. OBJECTIVE: Because polymorphonuclear neutrophils (PMN) interaction with ECs generates reactive oxygen species, we addressed the possible role of TRPM2 expressed in ECs in the mechanism of transendothelial migration of PMNs. METHODS AND RESULTS: We observed defective PMN transmigration in response to lipopolysaccharide challenge in adult mice in which the EC expressed TRPM2 is conditionally deleted (Trpm2iΔEC ). PMN interaction with ECs induced the entry of Ca2+ in ECs via the EC-expressed TRPM2. Prevention of generation of adenosine diphosphoribose in ECs significantly reduced Ca2+ entry in response to PMN activation of TRPM2 in ECs. PMNs isolated from gp91phox-/- mice significantly reduced Ca2+ entry in ECs via TRPM2 as compared with wild-type PMNs and failed to induce PMN transmigration. Overexpression of the adenosine diphosphoribose insensitive TRPM2 mutant channel (C1008→A) in ECs suppressed the Ca2+ entry response. Further, the forced expression of TRPM2 mutant channel (C1008→A) or silencing of poly ADP-ribose polymerase in ECs of mice prevented PMN transmigration. CONCLUSIONS: Thus, endotoxin-induced transmigration of PMNs was secondary to TRPM2-activated Ca2+ signaling and VE-cadherin phosphorylation resulting in the disassembly of adherens junctions and opening of the paracellular pathways. These results suggest blocking TRPM2 activation in ECs is a potentially important means of therapeutically modifying PMN-mediated vascular inflammation.
RATIONALE: TRPM2 (transient receptor potential melastatin-2) expressed in endothelial cells (ECs) is a cation channel mediating Ca2+ entry in response to intracellular generation of adenosine diphosphoribose-the TRPM2 ligand. OBJECTIVE: Because polymorphonuclear neutrophils (PMN) interaction with ECs generates reactive oxygen species, we addressed the possible role of TRPM2 expressed in ECs in the mechanism of transendothelial migration of PMNs. METHODS AND RESULTS: We observed defective PMN transmigration in response to lipopolysaccharide challenge in adult mice in which the EC expressed TRPM2 is conditionally deleted (Trpm2iΔEC ). PMN interaction with ECs induced the entry of Ca2+ in ECs via the EC-expressed TRPM2. Prevention of generation of adenosine diphosphoribose in ECs significantly reduced Ca2+ entry in response to PMN activation of TRPM2 in ECs. PMNs isolated from gp91phox-/- mice significantly reduced Ca2+ entry in ECs via TRPM2 as compared with wild-type PMNs and failed to induce PMN transmigration. Overexpression of the adenosine diphosphoribose insensitive TRPM2 mutant channel (C1008→A) in ECs suppressed the Ca2+ entry response. Further, the forced expression of TRPM2 mutant channel (C1008→A) or silencing of poly ADP-ribose polymerase in ECs of mice prevented PMN transmigration. CONCLUSIONS: Thus, endotoxin-induced transmigration of PMNs was secondary to TRPM2-activated Ca2+ signaling and VE-cadherin phosphorylation resulting in the disassembly of adherens junctions and opening of the paracellular pathways. These results suggest blocking TRPM2 activation in ECs is a potentially important means of therapeutically modifying PMN-mediated vascular inflammation.
Authors: Heather Knowles; Justin W Heizer; Yuan Li; Kathryn Chapman; Carol Anne Ogden; Karl Andreasen; Ellen Shapland; Gary Kucera; Jennifer Mogan; Jessica Humann; Laurel L Lenz; Alastair D Morrison; Anne-Laure Perraud Journal: Proc Natl Acad Sci U S A Date: 2011-06-27 Impact factor: 11.205
Authors: Patric Turowski; Roberta Martinelli; Rebecca Crawford; David Wateridge; Anna-Pia Papageorgiou; Maria Grazia Lampugnani; Alexander C Gamp; Dietmar Vestweber; Peter Adamson; Elisabetta Dejana; John Greenwood Journal: J Cell Sci Date: 2008-01-01 Impact factor: 5.285
Authors: Joachim R Göthert; Sonja E Gustin; J Anke M van Eekelen; Uli Schmidt; Mark A Hall; Stephen M Jane; Anthony R Green; Berthold Göttgens; David J Izon; C Glenn Begley Journal: Blood Date: 2004-06-08 Impact factor: 22.113
Authors: Alexander H Shannon; Craig T Elder; Guanyi Lu; Gang Su; Alexis Mast; Morgan D Salmon; William G Montgomery; Michael D Spinosa; Gilbert R Upchurch; Ashish K Sharma Journal: FASEB J Date: 2020-06-07 Impact factor: 5.191
Authors: Eric K Patterson; Carolina Gillio-Meina; Claudio M Martin; Douglas D Fraser; Logan R Van Nynatten; Marat Slessarev; Gediminas Cepinskas Journal: Exp Biol Med (Maywood) Date: 2021-07-22